ADVM (Adverum Biotechnologies) โ 30-Min Long Trade Setup! ๐
๐น Asset: ADVM โ NASDAQ
๐น Timeframe: 30-Min Chart
๐น Setup Type: Bullish Breakout (Rising Wedge & Fibonacci Confluence)
๐ Trade Plan (Long Position)
โ
Entry Zone: Above $5.38 (Breakout Confirmation)
โ
Stop-Loss (SL): Below $5.09 (Key Support Level)
๐ฏ Take Profit Targets
๐ TP1: $5.85 (Resistance L
Adverum Biotechnologies Inc. | Chart & Forecast SummaryKey Indicators On Trade Set Up In General
1. Push Set Up
2. Range Set up
3. Break & Retest Set Up
Notes On Session
# Adverum Biotechnologies Inc.
- Double Formation
* A+ Set Up)) At 16.5800 USD | Subdivision 1
* No Trade)) | Invalid Pattern Confirmation | Subdivision 2
- Triple Formation
* (Continu
ADVM - Biotech Long ShotBiotechs are still beaten up, especially the gene therapy disrupter stocks, so continuing to buy a little bit here and a little bit here of some of these stocks.
These are lottery stocks, they have few if any marketable products, but the idea is if they do come out with a block buster, well winner
Adverum Biotechnologies, Inc.On the above bi-Weekly chart price action has corrected over 90% since June 2020. A number of reasons now exist to be bullish , including:
1) A strong buy signal prints (not shown).
2) Regular bullish divergence . Multiple oscillators printing divergence.
3) Price action confirms support on past re
ADVM | Adverum Biotechnologies, Inc. Healthcare US STOCKSBullish trend ๐
Stock: ADVM | Adverum Biotechnologies, Inc.
Healthcare | Biotechnology | USA | NASDAQ
Trend Analysis: The stock's price has been consistently following a uptrend characterized by higher highs and higher lows. Traders may look for buying opportunities as the stock approaches the b
time to add target 2.25time to add target 2.25 stoploss 1.13..Adverum is moving forward with its eye disease gene therapy that caused headaches in April 2021, but is doing so with fewer staff on board.
The biotech is laying off 78 employees, or about 38% of its workforce, in order to conserve cash and keep the lights on
ADVM Technical Analysis ๐งAdverum Biotechnologies Inc is a US-based clinical-stage gene therapy company. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. The company has primarily generated revenue through license, research and collabo
See all ideasย
Displays a symbol's price movements over previous years to identify recurring trends.